GOLDMAN SACHS GROUP INC - COCRYSTAL PHARMA INC ownership

COCRYSTAL PHARMA INC's ticker is COCP and the CUSIP is 19188J300. A total of 32 filers reported holding COCRYSTAL PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of COCRYSTAL PHARMA INC
ValueSharesWeighting
Q2 2022$5,000
-54.5%
12,747
-27.9%
0.00%
Q4 2021$11,000
-93.4%
17,675
-88.8%
0.00%
Q3 2021$166,000
-4.0%
157,952
+14.3%
0.00%
Q2 2021$173,000
+46.6%
138,168
+62.1%
0.00%
Q1 2021$118,000
+168.2%
85,240
+164.1%
0.00%
Q4 2020$44,000
-47.0%
32,270
-63.9%
0.00%
Q3 2020$83,000
-45.4%
89,388
+115.4%
0.00%
Q2 2018$152,00041,5030.00%
Other shareholders
COCRYSTAL PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 6,110,657$7,638,0001.08%
Altium Capital Management LP 776,000$970,0000.22%
Alyeska Investment Group, L.P. 2,750,100$3,438,0000.04%
Virtu Financial LLC 116,625$146,0000.01%
Parallel Advisors, LLC 184,708$231,0000.01%
Renaissance Technologies 2,593,933$3,242,0000.00%
CIM, LLC 11,000$12,0000.00%
Western Wealth Management, LLC 19,115$24,0000.00%
Mariner, LLC 200,055$250,0000.00%
BRIGHTON JONES LLC 36,000$45,0000.00%
View complete list of COCRYSTAL PHARMA INC shareholders